Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.99 USD | +4.74% | -4.78% | -33.44% |
Mar. 25 | Esperion Shares Continue Rise After Friday's FDA Approval for Nexlizet, Nexletol | DJ |
Mar. 25 | Sector Update: Health Care Stocks Steady Premarket Monday | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.44% | 360M | |
+26.47% | 661B | |
+26.74% | 566B | |
-6.33% | 352B | |
+19.35% | 332B | |
+4.23% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.04% | 145B |
- Stock Market
- Equities
- ESPR Stock
- News Esperion Therapeutics, Inc.
- Transcript : Esperion Therapeutics, Inc., Q4 2023 Earnings Call, Feb 27, 2024